Antibody formation to enzyme therapy in classic infantile Pompe disease: implications of patient age
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2474
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antibody formation to enzyme therapy in classic infantile Pompe disease: implications of patient age ; volume:14 ; number:2 ; day:29 ; month:5 ; year:2013 ; pages:1 ; date:5.2013
BMC musculoskeletal disorders ; 14, Heft 2 (29.5.2013), 1, 5.2013
- Urheber
-
van Gelder, C.
- Beteiligte Personen und Organisationen
-
Kroos, M.
Özkan, L.
Plug, I.
Reuser, A.
van der Ploeg, A.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2474-14-S2-P18
- URN
-
urn:nbn:de:1111-2016043026570
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- van Gelder, C.
- Kroos, M.
- Özkan, L.
- Plug, I.
- Reuser, A.
- van der Ploeg, A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cognitive outcome of classic infantile Pompe patients receiving enzyme therapy
Effects of immunomodulation in classic infantile Pompe patients with high antibody titers
Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease
Distal muscle weakness is a common and early feature in long-term enzyme-treated classic infantile Pompe patients
Improved Enzyme Replacement Therapy with Cipaglucosidase Alfa/Miglustat in Infantile Pompe Disease
Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy
A higher dose of enzyme therapy in patients with classic infantile Pompe disease seems to improve ventilator-free survival and motor function
Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy
Enzyme replacement therapy (ERT) in pompe disease
Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy
Enzymersatztherapie bei Patienten mit infantiler Verlaufsform des Morbus Pompe in Deutschland
A Severe Form of Non-Classic Pompe's Disease with Normal Creatinine Kinase Level
Cognitive outcome of classic infantile Pompe patients receiving enzyme therapy
Effects of immunomodulation in classic infantile Pompe patients with high antibody titers
Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease
Distal muscle weakness is a common and early feature in long-term enzyme-treated classic infantile Pompe patients
Improved Enzyme Replacement Therapy with Cipaglucosidase Alfa/Miglustat in Infantile Pompe Disease
Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy
A higher dose of enzyme therapy in patients with classic infantile Pompe disease seems to improve ventilator-free survival and motor function
Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy
Enzyme replacement therapy (ERT) in pompe disease
Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy
Enzymersatztherapie bei Patienten mit infantiler Verlaufsform des Morbus Pompe in Deutschland
A Severe Form of Non-Classic Pompe's Disease with Normal Creatinine Kinase Level
Cognitive outcome of classic infantile Pompe patients receiving enzyme therapy
Effects of immunomodulation in classic infantile Pompe patients with high antibody titers
Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease
Distal muscle weakness is a common and early feature in long-term enzyme-treated classic infantile Pompe patients
Improved Enzyme Replacement Therapy with Cipaglucosidase Alfa/Miglustat in Infantile Pompe Disease
Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy
A higher dose of enzyme therapy in patients with classic infantile Pompe disease seems to improve ventilator-free survival and motor function
Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapy
Enzyme replacement therapy (ERT) in pompe disease
Long term clinical history of an Italian cohort of infantile onset Pompe disease treated with enzyme replacement therapy
Enzymersatztherapie bei Patienten mit infantiler Verlaufsform des Morbus Pompe in Deutschland